These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18626630)

  • 21. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Dahlöf C; Maassen Van Den Brink A
    Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans.
    de Vries T; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2020 Jul; 211():107528. PubMed ID: 32173558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute migraine therapy: new drugs and new approaches.
    Monteith TS; Goadsby PJ
    Curr Treat Options Neurol; 2011 Feb; 13(1):1-14. PubMed ID: 21110235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Headache currents commentary.
    Peatfield R
    Headache; 2012 Apr; 52(4):715. PubMed ID: 22414189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging targets in migraine.
    Hoffmann J; Goadsby PJ
    CNS Drugs; 2014 Jan; 28(1):11-7. PubMed ID: 24318669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological approaches to migraine.
    Diener HCh
    J Neural Transm Suppl; 2003; (64):35-63. PubMed ID: 12830928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological opportunities and pitfalls in the therapy of migraine.
    May A; Goadsby PJ
    Curr Opin Neurol; 2001 Jun; 14(3):341-5. PubMed ID: 11371757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Kayser V; Aubel B; Hamon M; Bourgoin S
    Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic advances in migraine.
    Solomon GD
    J Clin Pharmacol; 1993 Mar; 33(3):200-9. PubMed ID: 8385160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of triptans in the treatment of patients with migraine.
    Jamieson DG
    Am J Med; 2002 Feb; 112(2):135-40. PubMed ID: 11835952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The triptan formulations : how to match patients and products.
    Rapoport AM; Tepper SJ; Bigal ME; Sheftell FD
    CNS Drugs; 2003; 17(6):431-47. PubMed ID: 12697002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute treatment of migraine attacks.
    Ferrari MD; Haan J
    Curr Opin Neurol; 1995 Jun; 8(3):237-42. PubMed ID: 7551126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future drugs for migraine.
    Farinelli I; De Filippis S; Coloprisco G; Missori S; Martelletti P
    Intern Emerg Med; 2009 Oct; 4(5):367-73. PubMed ID: 19551474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.
    Labruijere S; Ibrahimi K; Chan KY; Maassenvandenbrink A
    Expert Opin Drug Discov; 2013 Nov; 8(11):1309-23. PubMed ID: 23962310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute treatments: some blind alleys.
    Ramadan NM
    Curr Med Res Opin; 2001; 17 Suppl 1():s71-80. PubMed ID: 12463283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical approaches to migraine management.
    Diamond S; Wenzel R
    CNS Drugs; 2002; 16(6):385-403. PubMed ID: 12027785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.